# Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

> **NCT00368654** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 12 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Raptiva

## Key facts

- **NCT ID:** NCT00368654
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368654, "Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00368654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*